ISATUXIMAB: payments to doctors
Payments that named ISATUXIMAB as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $31K
- Providers
- 9
- Transactions
- 29
- Average per transaction
- $1,056
The per-transaction average — $1,056 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9 providers the average total is $3,404, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $30,637 | 100.0% |